High Quality Content by WIKIPEDIA articles! Rituximab, sold under the trade names Rituxan and MabThera, is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cells. Rituximab is used in the treatment of many lymphomas, leukemias, and some autoimmune disorders.Rituximab was developed by IDEC Pharmaceuticals. Based on its safety and effectiveness in clinical trials, rituximab was approved by the U.S. Food and Drug Administration in 1997 for B cell non-Hodgkin lymphoma resistant to other chemotherapy regimens.

Данное издание не является оригинальным. Книга печатается по технологии принт-он-деманд после получения заказа.